NLRP3 and Hyperglycemia: Interestingly, a recent study has keenly investigated hyperglycemia attenuated anticancer effects and augmented its cardiotoxicity in cellular models through mechanisms of regulating NLRP3 inflammasome and MyD88 signaling [25], suggesting hyperglycemia increased cytokine storm in human cancer cells and cardiotoxic induced by anticancer therapies [25].